Blog
DNA, Drinks, and Dupuytren
While it’s estimated Dupuytren’s disease impacts over 10 million Americans, the current treatment options available to patients – mainly surgical procedures – are inadequate. Medicine has been focused on treating Dupuytren-related finger deformities rather than preventative measures or finding a cure at the biological level. Yet, with increasing recognition of
AmazonSmile is Closing: Last Chance to Support Dupuytren Research!
We’re Grateful! We’re very grateful for the support we have received under the Amazon Smile program, in which a percent of Amazon purchase revenues are donated to the Dupuytren Research Group. We’re Also Sad. Sadly, Amazon is withdrawing this program from most of the charities participating in this program –
This Puzzle Needs Y, O, and U to Solve!
Dupuytren disease remains a puzzle, a puzzle with so many clues, but not enough to solve – yet. The Dupuytren Research Group is conducting research to find clues hidden in the blood. Why? A Dupuytren blood test is the single most important tool we need to understand why some people
Reverse Giving Tuesday: A video for you!
It’s Giving Tuesday, a traditional fundraising push for nonprofits. The Dupuytren Research Group is flipping this to Reverse Giving Tuesday with a gift for you: a new video seminar reviewing Dupuytren disease, its challenges, and the strategy behind our research for a cure. https://www.youtube.com/watch?v=LkOronhIgQU Of course, your financial support is critical
The ‘Most Common Crippling Hand Condition’ You’ve Never Heard Of
The Washington Post just published an article about Dupuytren disease mentioning the Dupuytren Research Group and two of its directors, Gary Pess MD and Charles Eaton MD.
Three Exciting Dupuytren Updates and a Public Seminar
I want to share three exciting Dupuytren updates with you this Halloween. The first update is the growing use of artificial intelligence (AI) in medical research. The term “Artificial Intelligence” is a little misleading. Today, AI is about computerized pattern-matching rather than thinking and consciousness, but it’s still amazing. The
Three Exciting Dupuytren Updates and a Public Seminar
I want to share three exciting Dupuytren updates with you this Halloween.
The first update is the growing use of artificial intelligence (AI) in medical research.
Disease Modifying Anti-Dupuytren Drugs
The path to a Dupuytren cure is connected to the story of drugs for rheumatoid arthritis. The evolution of rheumatoid drug treatment dates back centuries, based on guesswork and trial and error.
Disease Modifying AntiDupuytren Drugs
The path to a Dupuytren cure is connected to the story of drugs for rheumatoid arthritis. The evolution of rheumatoid drug treatment dates back centuries, based on guesswork and trial and error. During this time, hundreds of rheumatoid “cures” were recommended – herbs, diets, bedrest, baths, special clothing, radioactive exposure,
Recent Dupuytren Publications
- Patient Experiences With Hand Surgery in the Office Versus Ambulatory Surgery Center
- Collagenase Treatment Versus Needle Fasciotomy for Single-Digit Dupuytren Contractures: A Meta-Analysis of Randomized Controlled Trials
- Exploring the potential relationship between frozen shoulder and Dupuytren's disease through bioinformatics analysis and machine learning
- Objective and subjective assessment of Dupuytren's contracture
- Can You Go the Distance: Collagenase <em>Clostridium histolyticum</em> Manipulation at 1 Month after Injection
